These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 32544494)
1. Elevated soluble E-cadherin during the epithelial-mesenchymal transition process and as a diagnostic marker in colorectal cancer. Zhu S; Zhao G; Zhao X; Zhan X; Cai M; Geng C; Pu Q; Zhao Q; Fu Q; Huang C; Wang Q Gene; 2020 Sep; 754():144899. PubMed ID: 32544494 [TBL] [Abstract][Full Text] [Related]
2. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
3. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925 [TBL] [Abstract][Full Text] [Related]
4. Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer. Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF Oncotarget; 2016 Sep; 7(39):64136-64147. PubMed ID: 27580057 [TBL] [Abstract][Full Text] [Related]
5. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway. Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069 [TBL] [Abstract][Full Text] [Related]
6. HOXD9 promote epithelial-mesenchymal transition and metastasis in colorectal carcinoma. Liu M; Xiao Y; Tang W; Li J; Hong L; Dai W; Zhang W; Peng Y; Wu X; Wang J; Chen Y; Bai Y; Lin J; Yang Q; Wang Y; Lin Z; Liu S; Xiong J; Wang J; Xiang L Cancer Med; 2020 Jun; 9(11):3932-3943. PubMed ID: 32281284 [TBL] [Abstract][Full Text] [Related]
7. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin. Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293 [TBL] [Abstract][Full Text] [Related]
8. JianPi JieDu Recipe Inhibits Epithelial-to-Mesenchymal Transition in Colorectal Cancer through TGF- Liu X; Ji Q; Deng W; Chai N; Feng Y; Zhou L; Sui H; Li C; Sun X; Li Q Biomed Res Int; 2017; 2017():2613198. PubMed ID: 28299321 [TBL] [Abstract][Full Text] [Related]
9. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition. Yang Z; Wu D; Chen Y; Min Z; Quan Y Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022 [TBL] [Abstract][Full Text] [Related]
10. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα. Xin H; Wang C; Liu Z BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631 [TBL] [Abstract][Full Text] [Related]
11. Alpha B-crystallin promotes the invasion and metastasis of colorectal cancer via epithelial-mesenchymal transition. Shi C; Yang X; Bu X; Hou N; Chen P Biochem Biophys Res Commun; 2017 Aug; 489(4):369-374. PubMed ID: 28506831 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1. Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890 [TBL] [Abstract][Full Text] [Related]
13. Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT. Ma J; Zhao J; Lu J; Wang P; Feng H; Zong Y; Ou B; Zheng M; Lu A Tumour Biol; 2016 Jul; 37(7):9077-88. PubMed ID: 26762412 [TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling. Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333 [TBL] [Abstract][Full Text] [Related]
15. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT. Chen J; Zhang H; Chen Y; Qiao G; Jiang W; Ni P; Liu X; Ma L Exp Cell Res; 2017 Mar; 352(1):104-112. PubMed ID: 28161537 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic suppression of E-cadherin expression by Snail2 during the metastasis of colorectal cancer. Hu Y; Dai M; Zheng Y; Wu J; Yu B; Zhang H; Kong W; Wu H; Yu X Clin Epigenetics; 2018 Dec; 10(1):154. PubMed ID: 30541610 [TBL] [Abstract][Full Text] [Related]
17. CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer. Wang YS; Kou Y; Zhu RT; Han BW; Li CH; Wang HJ; Wu HB; Xia TM; Che XM Dis Markers; 2022; 2022():9025668. PubMed ID: 36277982 [TBL] [Abstract][Full Text] [Related]
18. The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC). Wang Y; Wu Z; Hu L Eur J Pharmacol; 2018 Sep; 834():45-53. PubMed ID: 30017802 [TBL] [Abstract][Full Text] [Related]
19. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer. Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636 [TBL] [Abstract][Full Text] [Related]
20. Claudin-7 downregulation induces metastasis and invasion in colorectal cancer via the promotion of epithelial-mesenchymal transition. Wang K; Li T; Xu C; Ding Y; Li W; Ding L Biochem Biophys Res Commun; 2019 Jan; 508(3):797-804. PubMed ID: 30528239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]